These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11134813)
1. Changes of fasting plasma total homocysteine in the early phase of renal transplantation. Huh W; Kim B; Kim SJ; Kim YG; Kim DJ; Cho JW; Oh HY Transplant Proc; 2000 Dec; 32(8):2811-3. PubMed ID: 11134813 [No Abstract] [Full Text] [Related]
2. Folic acid supplementation and homocyst(e)ine level in renal transplant recipients. Grandtnerová B; Laca L; Gábor D; Gregová E; Korónyi S Transplant Proc; 2001; 33(1-2):2049-50. PubMed ID: 11267620 [No Abstract] [Full Text] [Related]
3. Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients. Arnadottir M; Hultberg B Transplantation; 1997 Oct; 64(7):1087. PubMed ID: 9381536 [No Abstract] [Full Text] [Related]
4. Hyperhomocysteinemia in renal transplant recipients with cyclosporine. Kim SI; Yoo TH; Song HY; Hwang JH; Lee HY; Han DS; Moon JI; Kim YS; Park KI; Paeng KJ; Choi KH Transplant Proc; 2000 Nov; 32(7):1878-9. PubMed ID: 11119981 [No Abstract] [Full Text] [Related]
6. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Winkelmayer WC; Huber A; Wagner OF; Hörl WH; Sunder-Plassmann G; Födinger M Kidney Int; 2005 May; 67(5):1980-5. PubMed ID: 15840047 [TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy. Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332 [TBL] [Abstract][Full Text] [Related]
8. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946 [TBL] [Abstract][Full Text] [Related]
9. Plasma folate adequacy as determined by homocysteine level. Lewis CA; Pancharuniti N; Sauberlich HE Ann N Y Acad Sci; 1992 Sep; 669():360-2. PubMed ID: 1444047 [No Abstract] [Full Text] [Related]
10. Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study. Laurés AS; Gomez E; Alvarez V; Coto E; Baltar J; Alvarez-Grande J Transplant Proc; 2003 Aug; 35(5):1739-41. PubMed ID: 12962777 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients. Abdelfatah A; Ducloux D; Toubin G; Motte G; Alber D; Chalopin JM Transplantation; 2002 Feb; 73(4):663-5. PubMed ID: 11889451 [TBL] [Abstract][Full Text] [Related]
12. Effect of folic acid therapy on serum homocysteine level in renal transplant recipients. Savaj S; Rezakhani S; Porooshani F; Ghods AJ Transplant Proc; 2002 Sep; 34(6):2419. PubMed ID: 12270462 [No Abstract] [Full Text] [Related]
13. Incidence and treatment of hyperhomocysteinemia after renal transplantation. Zantvoort FA; Waldmann J; Colic D; Lison AE Transplant Proc; 2001; 33(7-8):3679-80. PubMed ID: 11750566 [No Abstract] [Full Text] [Related]
14. Renal function, homocysteine, and other plasma thiol concentrations during the postrenal transplant period. Merouani A; Rozen R; Clermont MJ; Genest J Transplant Proc; 2002 Jun; 34(4):1159-60. PubMed ID: 12072303 [No Abstract] [Full Text] [Related]
18. Folic acid and Vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women. Dierkes J; Kroesen M; Pietrzik K Int J Vitam Nutr Res; 1998; 68(2):98-103. PubMed ID: 9565824 [TBL] [Abstract][Full Text] [Related]
19. Total homocysteine as a risk factor for vascular disease in renal transplant recipients. Juskowa J; Bartłomiejczyk J; Paczek L; Rowinski W; Szmidt J; Foroncewicz B; Mucha K; Plomiński YP Transplant Proc; 2002 Mar; 34(2):576-9. PubMed ID: 12009629 [No Abstract] [Full Text] [Related]
20. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]